Although clinical remission rates were also higher with extended induction, this difference did not reach statistical significance at week 16 (55% vs. 44%, p = 0.25) or 52 (67% vs. 53%, p = 0.22) (Figure 2 ).
← all excerpts
Extended High-Dose Tofacitinib Induction Improves Clinical Response in Ulcerative Colitis: A Multicenter Cohort Study.
1
0.2500
0.2500